OCTAPLASLG groupe sanguin AB subst sèche c solv
7680697800027
CH-69780
B05AA
06.01.1.
Active substances:
1 / 3
google
Details
- GTIN
- 7680697800027
- Pharmacode
- -
- Product number
- 6978001
- CPT
- -
- Packaging group
- -
- Unit
- Blutgruppe AB (1 Durchstechflasche mit Pulver und 1 Beutel mit Lösungsmittel, Transferset und Zubehör)
- Composition
- Praeparatio cryodesiccata: proteina plasmatis humani 9-14 g, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, acidum citricum monohydricum, acidum phosphoricum, glycinum, pro vitro corresp. natrium <40 mmol. Solvens: aqua ad iniectabile pro charta.
Articles (1)
octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
Pulver
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
proteina plasmatis humani
|
- | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
acidum phosphoricum
|
- | Substance | HNIDK |
|
glycinum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Authorization holder
Octapharma AG
8853 Lachen SZ
Authorization information
- Swissmedic authorization number
- 69780
- Drug name
- octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
- Galenic form
- PULMI
- ATC Code
- B05AA
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/11/2024
- Authorization expiration date
- 11/11/2029
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OCTAPLASLG groupe sanguin AB subst sèche c solv
- Description (DE)
- OCTAPLASLG Blutgruppe AB Trockensub c Solv
- Market launch
- 12/11/2024
- Narcotic (BTM)
- No